Skip to main content

Table 3 Summary of BP control and lipid management in included studies

From: Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials

Source Target for BP or lipid management Outcome
The MEDMAN study [15], 2007 BP: < 140/85 mmHg No significant difference
Faulkner [16], 2000 LDL-C: ≤ 100 mg/dL (2.6 mmol/L) No significant difference at 6 or 12 weeks
More patients achieved target in intervention than in control at 1 and 2 years (P < 0.05)
Olson [17], 2009 LDL-C and non-HDL-C: < 100 mg/dL (2.6 mmol/L) and < 130 mg/dL (3.3 mmol/L) for all patients, < 70 mg/dL (1.8 mmol/L) and < 100 mg/dL (2.6 mmol/L) for patients with diabetes, multivessel coronary disease, at least 1 recurrent coronary event, or current smokers No significant difference in maintaining LDL-C and non-HDL-C goal, and BP goal of < 130 mmHg
BP: < 140/90 mmHg for all patients, <130/80 mmHg for patients with diabetes or CKD More patients maintained a BP goal of < 140 mmHg in intervention than in control (P = 0.03)
Straka [18], 2005 LDL-C: ≤ 100 mg/dL (2.6 mmol/L) More patients achieved LDL-C goal in intervention than in control at 6.5 months and the following 18 months (P < 0.001)
  1. Abbreviations: BP blood pressure, CKD chronic kidney disease, CVD cardiovascular disease, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol.